Aminoamino Acids Infusion 8% W/v bulk supplier for pharma manufacturers

Aminoamino Acids Infusion 8% W/V Suppliers & Bulk Manufacturers

Available Forms: Solution for IV infusion

Available Strengths: 8 g per 100 mL (i.e., 80 g/L)

Reference Brands: Aminoplasmal 8%(EU); Aminomix 8%(India)

Amino Acids Infusion 8% w/v is a sterile IV solution used in parenteral nutrition to supply essential and non-essential amino acids. Designed for patients unable to consume food orally, it supports protein synthesis and nitrogen balance during recovery from surgery, trauma, or critical illness. Ideal for hospital and ICU use.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Amino Acids Infusion 8% w/v is a sterile intravenous solution formulated for parenteral nutrition in patients unable to eat or absorb nutrients orally. It contains a balanced mix of essential and non-essential amino acids, supporting protein synthesis, tissue repair, and nitrogen balance. This formulation is commonly used in hospitals and critical care settings for patients recovering from surgery, trauma, sepsis, or malnutrition. Administered alongside dextrose and lipid infusions, it forms a key component of total parenteral nutrition (TPN). Available in flexible infusion bags or glass bottles, it is an essential product for clinical nutrition and hospital supply chains.

Aminoamino Acids Infusion 8% W/V — third party manufacturing & bulk supply

Aminoamino Acids Infusion 8% W/V is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Aminoamino Acids Infusion 8% W/V is supplied as Solution for IV infusion — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Aminoamino Acids Infusion 8% W/V listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Aminoamino Acids Infusion 8% W/V →

Back to Listing

Frequently Asked Questions

Amino Acids Infusion is used as part of parenteral nutrition to provide essential and non-essential amino acids to patients who cannot obtain adequate nutrition through oral or enteral routes. It supports protein synthesis, tissue repair, wound healing, and overall nutritional status in critically ill, postoperative, malnourished, or hospitalized patients.

Amino Acids Infusion is composed of a sterile solution containing a balanced mixture of essential and non-essential amino acids dissolved in water for injection. Some formulations may also include electrolytes, depending on clinical requirements.

Common trade names vary by region and formulation and may include Aminoven, TrophAmine, Aminoplasmal, and other hospital-based parenteral nutrition brands.

Amino acid infusion products are manufactured by multiple pharmaceutical companies globally, including Fresenius Kabi, Baxter, B. Braun, and other approved parenteral nutrition manufacturers.

The generic name is Amino Acids Injection or Amino Acids Intravenous Infusion, depending on the formulation.

Brand names vary depending on composition and region, such as Aminoven, TrophAmine, and Aminoplasmal.

Amino acid infusion products are manufactured in GMP-approved facilities across the United States, Europe, Asia, and other regions, depending on the marketing authorization holder and brand.